Medexus Announces Fiscal Q2 2026 Results, Driven by Strong Year-To-Date Product-Level Performance of GRAFAPEX for Injection Pharmaceutical Investing
NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close Life Science Investing
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th Life Science Investing
KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance Life Science Investing
BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update Life Science Investing
Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update Life Science Investing
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights Life Science Investing
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended Life Science Investing
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended Life Science Investing
Sarah Cannon Research Institute and Bristol Myers Squibb Expand Strategic Collaboration to Accelerate Patient Enrollment and Broaden Access to Innovative Cancer Research Life Science Investing
